Similar articles

• In Reply: Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.

  Gill CM, Fowkes M, Shrivastava RK. Gill CM, et al. Neurosurgery. 2020 May 1;86(5):E483. doi: 10.1093/neuros/nyaa008. Neurosurgery. 2020. PMID: 31996907 No abstract available.
• Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.

  Gill CM, Fowkes M, Shrivastava RK. Gill CM, et al. Neurosurgery. 2020 Feb 1;86(2):E118-E123. doi: 10.1093/neuros/nyz342. Neurosurgery. 2020. PMID: 31504814 Review.
• Genomic and transcriptomic characterization of skull base chordoma.

  Sa JK, Lee IH, Hong SD, Kong DS, Nam DH. Sa JK, et al. Oncotarget. 2017 Jan 3;8(1):1321-1328. doi: 10.18632/oncotarget.13616. Oncotarget. 2017. PMID: 27901492 Free PMC article.
• [Chordoma].

  George B, Bresson D, Bouazza S, Froelich S, Mandonnet E, Hamdi S, Orabi M, Polivka M, Cazorla A, Adle-Biassette H, Guichard JP, Duet M, Gayat E, Vallée F, Canova CH, Riet F, Bolle S, Calugaru V, Dendale R, Mazeron JJ, Feuvret L, Boissier E, Vignot S, Puget S, Sainte-Rose C, Beccaria K. George B, et al. Neurochirurgie. 2014 Jun;60(3):63-140. doi: 10.1016/j.neuchi.2014.02.003. Epub 2014 May 23. Neurochirurgie. 2014. PMID: 24856008 Review. French.
• Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.

  Bohman LE, Koch M, Bailey RL, Alonso-Basanta M, Lee JY. Bohman LE, et al. World Neurosurg. 2014 Nov;82(5):806-14. doi: 10.1016/j.wneu.2014.07.005. Epub 2014 Jul 5. World Neurosurg. 2014. PMID: 25009165